眼瞼形成術市場の2030年までの予測：種類別、性別、サービス提供者別、地域別の世界分析

Stratistics MRCによると、眼瞼形成術の世界市場は2023年に40億8,000万米ドルを占め、予測期間中にCAGR 9.6％で成長し、2030年には77億5,000万米ドルに達すると予測されています。

眼瞼形成術と呼ばれる外科的手法は、まぶた、特に上まぶた、下まぶた、またはその両方の見た目を改善することを目的としています。この美容整形術は、より若々しく爽やかな外観を作り出すことができ、まぶたの老化に関連する数多くの問題に対処するために頻繁に使用されています。たるみや余分な皮膚、しわ、目の周りのふくらみなどの老化現象に対処するために、眼瞼形成術は頻繁に行われます。美容的な利点に加え、眼瞼形成術は上まぶたのたるみによって引き起こされる視覚障害などの実際的な問題にも役立ちます。顔を全体的に良く見せ、より若々しく見せるために眼瞼形成術を受ける人もいます。

英国美容整形外科医協会が実施した調査によると、ロックダウン後の対面治療に備え、ロックダウン中に外科手術のバーチャル診察の依頼が70％急増しました。

高齢化社会における手術需要の増加

人口の高齢化、可処分所得の増加、自分の見た目を改善したいという願望が、成長の原因となっています。さらに、中国、日本、韓国など、米国以外でもこの治療法の人気が高まっています。眼瞼形成術の需要増加の結果、非侵襲的な施術や最先端技術を含む斬新な治療法が開発されたことも、業界の拡大に寄与しています。若々しい外見を維持したいという高齢化社会の願望は眼瞼形成術の主要な市場促進要因であり、この動向は今後も続くと予想され、市場の拡大を支えています。

高い費用

手術の程度や外科医の能力、場所などの要素によって、米国における眼瞼形成術の一般的な費用は異なります。特に十分な健康保険や可処分所得がない場合、その法外な費用のために手術を受けることを躊躇する見込みのある患者もいます。さらに、手術には感染、出血、瘢痕形成などの副作用が生じる可能性があり、これが患者の治療意欲を減退させ、市場の成長を妨げています。

新しい手術法を利用したカスタマイズ

眼瞼形成術は、手術方法や技術の向上により、より安全で効率的なものとなっています。この手術は、低侵襲性技術、迅速な回復、より良い結果などの理由で、ますます人気が高まっています。眼瞼形成術の手順は、各患者のユニークな要求と目的に合わせてカスタマイズすることができます。例えば、上まぶたのたるみ、下まぶたのふくらみ、あるいは複合的な問題など、特定の症状を治療するために、外科医は手術方法を調整することがあります。さらに、プラズマ技術やレーザー支援機器などの技術開発の結果、市場は拡大しています。これらの機器は、精密かつ制御された組織切除と引き締めを提供し、隣接組織への害はほとんどないです。

健康保険適用による安全性への懸念

注目される眼瞼形成術関連の問題や有害事象は、社会的信頼を損ない、潜在的な患者を遠ざける可能性があります。安全性への懸念の結果、監督や規制が強化されるかもしれません。特定の患者にとって、眼瞼形成術の処置へのアクセスは、限られた保険適用または存在しない保険適用によって妨げられるかもしれません。潜在的な患者は、特に予算が限られている患者にとっては、施術の自己負担額によって落胆するかもしれません。美容整形、特に眼瞼形成術を管理する法律が改正されることにより、市場が影響を受ける可能性があります。規則やライセンシングの要件が厳しくなることで、施術にかかるコストが上昇し、施術者が減少する可能性があります。

COVID-19の影響

COVID-19の発生は、世界のヘルスケア産業の運営を妨げています。眼瞼形成術はCOVID-19の大流行によって大きな影響を受けています。世界のいくつかの国では、厳格な閉鎖と社会隔離政策が実施され、ヘルスケア・サービスへのアクセスが阻害され、眼瞼形成術を選択する患者数が減少しています。

予測期間中、上眼瞼形成術分野が最大となる見込み

上眼瞼形成術セグメントは、上まぶたの見た目を改善することを目的とした美容整形手術の一種であるため、有利な成長を遂げると推定されます。この手術は、加齢や遺伝、その他の要因によって引き起こされる様々な美的問題を治療するために頻繁に使用されます。上まぶたの余分な皮膚やしわ、視界を損なうフード状または下垂した上まぶた、上まぶた領域のふくらみや膨らんだ脂肪沈着などの懸念に対処することで、上まぶたの眼瞼形成術はより若々しく若返った外見を作り出すことを目的としており、眼瞼形成術市場の成長を牽引しています。

予測期間中、病院セグメントが最も高いCAGRを持つと予測される

病院で美容整形手術を受ける患者の増加や、最先端の医療技術を駆使してまぶたの外科手術を提供する病院の増加により、病院分野は予測期間中に最も高いCAGRの成長が見込まれています。術後の治療や指示は病院のスタッフによって行われ、疼痛管理、開放創のケア、腫れや打撲の軽減などの推奨が含まれます。患者が安定し、目が覚めたら、通常、退院となります。回復初期に避けるべき目のケア、薬物、活動に関する情報など、術後の詳細な指示は、病院のスタッフや外科医から患者に与えられることが多いです。

最大のシェアを占める地域：

アジア太平洋地域は、予測期間中に最大の市場シェアを占めると予測されています。これは、同地域に製薬・医療機器メーカーが存在すること、中国やインドなどの国々で老人人口が増加していることが、同地域の市場成長の要因となっています。さらに、低侵襲手術への志向が高まっているため、眼瞼形成術の市場は予測期間を通じて上昇すると予想されます。二重まぶた手術はアジア諸国、特に韓国で最も人気のある手術であり、この地域の市場成長を高めています。

CAGRが最も高い地域：

北米は、重要な主要企業が複数存在することと、この地域における医療機器の急速な技術進歩により、予測期間中に最も高いCAGRを示すと予測されます。市場拡大の主な要因は、レーザーリサーフェシングや皮膚充填剤を含む革新的で洗練された美容技術を使用して、目の外観を向上させるために眼瞼形成術の治療を受ける人の数が増加していることです。例えば、2021年の国際美容整形外科学会の報告書によると、米国では53,253件の眼瞼整形治療が完了したのに対し、同国では149,668件の眼瞼整形治療が完了したと推定されており、これが同地域市場の成長を促進しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の眼瞼形成術市場：種類別

• 上まぶたの眼瞼形成術
• 下まぶたの眼瞼形成術
• まぶたの混合手術

第6章 世界の眼瞼形成術市場：性別

• 女性
• 男性

第7章 世界の眼瞼形成術市場：サービス提供者別

• 病院
• クリニック
• 外来手術センター

第8章 世界の眼瞼形成術市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第9章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第10章 企業プロファイル

• Abbvie Inc
• Allergan
• Alma Lasers
• Cynosure
• Erchonia Corporation
• Galderma
• Grand Aespio Inc.
• Hologic
• Johnson & Johnson
• LightScalpel
• London Bridge Plastic Surgery
• Lumenis
• M A Corporation
• Medline industries, inc.
• Medtronic plc
• Merz Pharma
• Sientra
• Sisram Medical Ltd
• Surgical Holdings Ltd.
• Valeant Pharmaceuticals International
• Zimmer Biomet

List of Tables

• Table 1 Global Blepharoplasty Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 4 Global Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 5 Global Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 6 Global Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 7 Global Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 8 Global Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 9 Global Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 10 Global Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 11 Global Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 12 Global Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
• Table 13 North America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
• Table 14 North America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 15 North America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 16 North America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 17 North America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 18 North America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 19 North America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 20 North America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 21 North America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 22 North America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 23 North America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 24 North America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
• Table 25 Europe Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
• Table 26 Europe Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 27 Europe Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 28 Europe Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 29 Europe Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 30 Europe Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 31 Europe Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 32 Europe Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 33 Europe Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 34 Europe Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 35 Europe Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 36 Europe Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
• Table 37 Asia Pacific Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
• Table 38 Asia Pacific Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 39 Asia Pacific Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 40 Asia Pacific Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 41 Asia Pacific Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 42 Asia Pacific Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 43 Asia Pacific Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 44 Asia Pacific Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 45 Asia Pacific Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 46 Asia Pacific Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 47 Asia Pacific Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 48 Asia Pacific Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
• Table 49 South America Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
• Table 50 South America Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 51 South America Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 52 South America Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 53 South America Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 54 South America Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 55 South America Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 56 South America Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 57 South America Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 58 South America Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 59 South America Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 60 South America Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)
• Table 61 Middle East & Africa Blepharoplasty Market Outlook, By Country (2021-2030) ($MN)
• Table 62 Middle East & Africa Blepharoplasty Market Outlook, By Type (2021-2030) ($MN)
• Table 63 Middle East & Africa Blepharoplasty Market Outlook, By Upper Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 64 Middle East & Africa Blepharoplasty Market Outlook, By Lower Eyelid Blepharoplasty (2021-2030) ($MN)
• Table 65 Middle East & Africa Blepharoplasty Market Outlook, By Combination Eyelid Surgery (2021-2030) ($MN)
• Table 66 Middle East & Africa Blepharoplasty Market Outlook, By Gender (2021-2030) ($MN)
• Table 67 Middle East & Africa Blepharoplasty Market Outlook, By Female (2021-2030) ($MN)
• Table 68 Middle East & Africa Blepharoplasty Market Outlook, By Male (2021-2030) ($MN)
• Table 69 Middle East & Africa Blepharoplasty Market Outlook, By Service Provider (2021-2030) ($MN)
• Table 70 Middle East & Africa Blepharoplasty Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 71 Middle East & Africa Blepharoplasty Market Outlook, By Clinics (2021-2030) ($MN)
• Table 72 Middle East & Africa Blepharoplasty Market Outlook, By Ambulatory Surgical Centre (2021-2030) ($MN)

According to Stratistics MRC, the Global Blepharoplasty Market is accounted for $4.08 billion in 2023 and is expected to reach $7.75 billion by 2030 growing at a CAGR of 9.6% during the forecast period. A surgical technique called blepharoplasty aims to improve the appearance of the eyelids, specifically the upper, lower, or both. This cosmetic procedure can produce a more young and refreshed appearance and is frequently used to address numerous issues connected to the aging of the eyelids. In order to address aging symptoms such sagging or extra skin, wrinkles, and puffiness around the eyes, blepharoplasty is frequently performed. In addition to its cosmetic advantages, blepharoplasty can help with practical problems including visual impairment brought on by sagging upper eyelids. Some people get blepharoplasty to make their face look better overall and look more youthful.

According to a study conducted by the British Association of Aesthetic Plastic Surgeons, requests for virtual consultations for surgical procedures jumped by 70% during the lockdown in preparation for in-person treatment following the lockdown.

Market Dynamics:

Driver:

Increasing demand for the surgery among the aged population

The aging of the population, rising disposable money, and the desire to improve one's look are all contributing causes to the growth. Furthermore, the treatment is becoming more and more popular outside of the United States as well, including in China, Japan, and South Korea. The development of novel treatments, including non-invasive procedures and cutting-edge technologies, as a result of the increasing demand for blepharoplasty has also helped the industry expand. The aging population's desire to maintain a youthful appearance is a major market driver for blepharoplasty, and this trend is anticipated to persist in the years to come, supporting market expansion.

Restraint:

High cost

Depending on the degree of the procedure, as well as other elements including the surgeon's competence and location, the typical cost of blepharoplasty surgery in the United States varies. Some prospective patients are discouraged from having the surgery because of its exorbitant cost, especially those who lack sufficient health insurance or disposable income. Additionally, there is a chance that the surgery can have side effects like infection, bleeding, and scarring, which discourages patients from having the treatment done which hamper the growth of the market

Opportunity:

Customization utilizing new surgical methods

Blepharoplasty has become safer and more efficient thanks to improvements in surgical methods and technology. The operation is becoming more and more popular, in part because of minimally invasive techniques, quick recoveries, and better results. Procedures for blepharoplasty can be customized to each patient's unique requirements and objectives. In order to treat specific symptoms, such as upper eyelid sagging, lower eyelid puffiness, or a combination of problems, surgeons might tailor the procedure. Additionally, the market is expanding as a result of technological developments such plasma technology and laser-assisted devices, which offer precise and controlled tissue ablation and tightening with little harm to neighbouring tissues.

Threat:

Safety concerns with health insurance coverage

High-profile blepharoplasty-related problems or adverse events can damage public confidence and turn away potential patients. There may be more oversight and regulations as a result of safety concerns. For certain patients, access to blepharoplasty procedures may be hampered by limited or non-existent insurance coverage. Potential patients may be discouraged by the procedure's out-of-pocket cost, especially those who are on a limited budget. The market may be impacted by modifications to laws governing cosmetic surgery, especially blepharoplasty. Stricter rules or licensing requirements may raise the cost of practicing and reduce the availability of practitioners, which may have an impact on how accessible the treatment and the market.

COVID-19 Impact

The COVID-19 outbreak has hampered operations in the global healthcare industry. Blepharoplasty surgery has been significantly impacted by the COVID-19 pandemic. Strict lockdowns and social segregation policies have been put in place by several nations around the world, which have disrupted access to healthcare services and lowered the number of patients choosing to have blepharoplasty.

The upper eyelid blepharoplasty segment is expected to be the largest during the forecast period

The upper eyelid blepharoplasty segment is estimated to have a lucrative growth, as it is a type of cosmetic surgery that aims to improve the appearance of the upper eyelids. This surgery is frequently used to treat a variety of aesthetic issues brought on by aging, heredity, or other factors. By addressing concerns like extra skin and wrinkles on the top eyelids, hooded or drooping upper eyelids that may impair vision, and puffy or bulging fat deposits in the upper eyelid area, upper eyelid blepharoplasty aims to produce a more youthful and rejuvenated appearance thus driving the growth of the blepharoplasty market.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to witness the highest CAGR growth during the forecast period, due to the rise in patients having cosmetic surgery performed at hospitals as well as the increase in hospitals offering surgical procedures for the eyelid using cutting-edge medical technology. The postoperative treatment and instructions are given by hospital staff and may include recommendations for managing pain, caring for open wounds, and lowering swelling and bruising. Once a patient is stable and awake, they are typically released detailed postoperative instructions, including information on eye care, drugs, and activities to avoid during the early recovery phase, are frequently given to patients by hospital staff and surgeons.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the presence of pharmaceutical and medical device manufacturers in the area, as well as the increase in the geriatric population in nations like China and India, are both responsible for the market growth in this area. an increase in the number of elderly people, a rise in the number of people who have saggy or droopy upper eyelids as a result of sedentary lifestyles, and an increase in screen time as a result of the COVID-19 epidemic. Additionally, it is anticipated that the market for blepharoplasty would experience rise throughout the projection period because to the growing inclination for minimally invasive procedures. Double eyelid surgery is the most popular procedure in several Asian nations, particularly in Korea enhances the market growth in this region.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the existence of several significant key players and the rapid technological advancement of medical devices in this area. The main driver of the market's expansion is the rise in the number of people having blepharoplasty treatments to enhance the appearance of their eyes using innovative and sophisticated cosmetic techniques including laser resurfacing and dermal fillers. For instance, a report from the International Society of Aesthetic Plastic Surgery from 2021 estimates that 149,668 eyelid surgery treatments were completed there, compared to 53,253 in the U.S. which are propelling the growth of the regions market.

Key players in the market:

Some of the key players profiled in the Blepharoplasty Market include: Abbvie Inc, Allergan, Alma Lasers, Cynosure, Erchonia Corporation, Galderma, Grand Aespio Inc., Hologic, Johnson & Johnson, LightScalpel, London Bridge Plastic Surgery, Lumenis, M A Corporation, Medline industries, inc., Medtronic plc, Merz Pharma, Sientra, Sisram Medical Ltd, Surgical Holdings Ltd, Valeant Pharmaceuticals International and Zimmer Biomet.

Key Developments:

In October 2023, Allergan Aesthetics and Girls Inc. partner to speed the entry of young Women into Positions of Leadership in the STEM Field. The Allergan Aesthetics effort will focus specifically on leadership paths in STEM (science, technology, engineering, and math).

In October 2023, Johnson & Johnson Company announced a development and commercialization agreement with Sanofi for Janssen's extraintestinal pathogenic Escherichia coli (ExPEC) investigational vaccine program. The lead vaccine candidate is currently being evaluated in the Phase 3 E.mbrace study for the prevention of invasive E. coli disease (IED) in adults aged 60 years and older.

In July 2023, AbbVie and Calibr expand strategic collaboration to advance several preclinical and early-stage clinical assets. This partnership is an expansion of the collaboration AbbVie and Scripps Research formed in 2019 to develop a broad range of potential new and novel therapeutics.

Types Covered:

• Upper Eyelid Blepharoplasty
• Lower Eyelid Blepharoplasty
• Combination Eyelid Surgery

Genders Covered:

• Female
• Male

Service Providers Covered:

• Hospitals
• Clinics
• Ambulatory Surgical Centre

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Emerging Markets
• 3.7 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Blepharoplasty Market, By Type

• 5.1 Introduction
• 5.2 Upper Eyelid Blepharoplasty
• 5.3 Lower Eyelid Blepharoplasty
• 5.4 Combination Eyelid Surgery

6 Global Blepharoplasty Market, By Gender

• 6.1 Introduction
• 6.2 Female
• 6.3 Male

7 Global Blepharoplasty Market, By Service Provider

• 7.1 Introduction
• 7.2 Hospitals
• 7.3 Clinics
• 7.4 Ambulatory Surgical Centre

8 Global Blepharoplasty Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.8 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 Abbvie Inc
• 10.2 Allergan
• 10.3 Alma Lasers
• 10.4 Cynosure
• 10.5 Erchonia Corporation
• 10.6 Galderma
• 10.7 Grand Aespio Inc.
• 10.8 Hologic
• 10.9 Johnson & Johnson
• 10.10 LightScalpel
• 10.11 London Bridge Plastic Surgery
• 10.12 Lumenis
• 10.13 M A Corporation
• 10.14 Medline industries, inc.
• 10.15 Medtronic plc
• 10.16 Merz Pharma
• 10.17 Sientra
• 10.18 Sisram Medical Ltd
• 10.19 Surgical Holdings Ltd.
• 10.20 Valeant Pharmaceuticals International
• 10.21 Zimmer Biomet